Runben Biotechnology Co., Ltd. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Positive results in Jun 25

INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
NET SALES(Q) Highest at CNY 649.78 MM
OPERATING PROFIT(Q) Highest at CNY 166.23 MM

With ROE of 13.97%, it has a attractive valuation with a 0.82 Price to Book Value

Mojo Parameters

Stock DNA

Industry

FMCG

Market cap

CNY 1,781 Million (Micro Cap)

P/E

6.00

Industry P/E

Dividend Yield

1.47%

Debt Equity

-0.65

Return on Equity

13.97%

Price to Book

0.82

Revenue and Profits:

Net Sales:

650 Million

(Quarterly Results - Jun 2025)

Net Profit:

143 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-22.86%

6 Months

3.89%

1 Year

25.09%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Runben Biotechnology Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

31.30%

EBIT Growth (5y)

30.32%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.65

Sales to Capital Employed (avg)

85.30

Tax Ratio

14.76%

Dividend Payout Ratio

55.26%

Pledged Shares

Institutional Holding

ROCE (avg)

28.62%

ROE (avg)

13.24%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.82

EV to EBIT

1.11

EV to EBITDA

1.04

EV to Capital Employed

0.48

EV to Sales

0.25

PEG Ratio

Dividend Yield

1.47%

ROCE (Latest)

43.16%

ROE (Latest)

13.97%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 13.74% vs 33.61% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -0.90% vs 47.10% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "649.80",
          "val2": "571.30",
          "chgp": "13.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "166.20",
          "val2": "161.30",
          "chgp": "3.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "143.30",
          "val2": "144.60",
          "chgp": "-0.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "247.00%",
          "val2": "273.10%",
          "chgp": "-2.61%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 27.35% vs 20.80% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 32.83% vs 41.25% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,303.30",
          "val2": "1,023.40",
          "chgp": "27.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "329.40",
          "val2": "264.60",
          "chgp": "24.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.40",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "300.20",
          "val2": "226.00",
          "chgp": "32.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "236.40%",
          "val2": "237.10%",
          "chgp": "-0.07%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

649.80

571.30

13.74%

Operating Profit (PBDIT) excl Other Income

166.20

161.30

3.04%

Interest

0.00

Exceptional Items

-4.00

0.00

Consolidate Net Profit

143.30

144.60

-0.90%

Operating Profit Margin (Excl OI)

247.00%

273.10%

-2.61%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 13.74% vs 33.61% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -0.90% vs 47.10% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,303.30

1,023.40

27.35%

Operating Profit (PBDIT) excl Other Income

329.40

264.60

24.49%

Interest

0.20

0.40

-50.00%

Exceptional Items

3.60

0.00

Consolidate Net Profit

300.20

226.00

32.83%

Operating Profit Margin (Excl OI)

236.40%

237.10%

-0.07%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 27.35% vs 20.80% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 32.83% vs 41.25% in Dec 2023

All Annual Results

Company CV

About Runben Biotechnology Co., Ltd.

Runben Biotechnology Co., Ltd.

FMCG

No Details Available.

Company Coordinates

No Company Details Available